SAN FRANCISCO, July 31, 2023 (GLOBE NEWSWIRE) — Hagens Berman urges BioXcel Therapeutics, Inc. (NASDAQ: BTAI) investors who suffered substantial losses to submit your losses now. Class Period: Dec. 15, 2021 – June 28, 2023 Lead Plaintiff Deadline: September 5, 2023 Visit: www.hbsslaw.com/investor-fraud/BTAI Contact An Attorney Now: BTAI@hbsslaw.com 844-916-0895 BioXcel…Read More
HAGENS BERMAN NATIONAL TRIAL ATTORNEYS Encourages BioXcel Therapeutics BTAI Investors with Substantial Losses to Contact Firms Attorneys Securities Fraud Class Action Filed
